Can male vaccination reduce the burden of human papillomavirus-related disease in the United States?

Low, Garren M I; Attiga, Yasser S; Garg, Gaurav; Schlegal, Richard; Gallicano, G Ian

Low, Garren M I; Attiga, Yasser S; Garg, Gaurav; Schlegal, Richard; Gallicano, G Ian.

Affiliation

Low GM; Southern California Clinical and Translational Sciences Institute, University of Southern California, Los Angeles, California, USA.

Viral Immunol ; 25(3): 174-86, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22691099

Subject(s)

Papillomaviridae/immunology; Papillomavirus Infections/epidemiology; Papillomavirus Infections/prevention & control; Papillomavirus Vaccines/therapeutic use; Uterine Cervical Neoplasms/epidemiology; Uterine Cervical Neoplasms/prevention & control; Adolescent; Adult; Child; Clinical Trials as Topic; Female; Homosexuality, Male; Humans; Male; Papillomavirus Infections/immunology; Papillomavirus Infections/virology; Papillomavirus Vaccines/administration & dosage; United States/epidemiology; Uterine Cervical Neoplasms/immunology; Uterine Cervical Neoplasms/virology; Vaccination; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Papillomaviridae / Uterine Cervical Neoplasms / Papillomavirus Infections / Papillomavirus Vaccines Type of study: Prognostic_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Viral Immunol Journal subject: ALERGIA E IMUNOLOGIA / VIROLOGIA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google